Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil boosts hair growth by activating PGHS-1.

Some common medications can harm male fertility, but many effects can be reversed.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The method effectively detects banned substances in urine for sports antidoping.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Certain transporters are found in human hair follicles and may affect hair growth and loss.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.